Purpose of Review <p>This paper provides a discussion of the investment climate in the life sciences industry. The authors explore recent and long-term market trends, particularly with the advent of advanced therapies. We explore differences between market sub-segments and provide some key considerations for evaluating future projections.</p> Recent Findings <p>The life sciences market has historically generated robust long-term returns based on strong market fundamentals. After a decade of consistent results, the last five years have greatly exacerbated the risk and uncertainty. The market exploded with eyepopping valuations during COVID-19, only to suffer massive funding challenges in the years that followed. The recent bumpiness raises major questions about a previously stable set of market expectations.</p> Summary <p>Despite the recent turbulence, we remain bullish on future horizon over longer term time horizons. In time, the fundamentals will ultimately reward investors and companies with solid financial performance. Platform technologies will particularly enjoy outsized returns by enabling the next generation of therapeutic modalities.</p>